{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:28:32Z","timestamp":1794940112069,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["1364-19"],"award-info":[{"award-number":["1364-19"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["TRAN1-14003"],"award-info":[{"award-number":["TRAN1-14003"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14190"],"award-info":[{"award-number":["DISC2-14190"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["TRAN1-14716"],"award-info":[{"award-number":["TRAN1-14716"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA210087"],"award-info":[{"award-number":["CA210087"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>NKp46 is a critical regulator of natural killer (NK) cell immunity, but its function in non-NK innate immune cells remains unclear. Here, we show that NKp46 is indispensable for expressing IL-2 receptor-\u03b1 (IL-2R\u03b1) by non-NK liver-resident type-1 innate lymphoid cells (ILC1s). Deletion of NKp46 reduces IL-2R\u03b1 on ILC1s by downregulating NF-\u03baB signaling, thus impairing ILC1 proliferation and cytotoxicity in vitro and in vivo. The binding of anti-NKp46 antibody to NKp46 triggers the activation of NF-\u03baB, the expression of IL-2R\u03b1, interferon-\u03b3 (IFN-\u03b3), tumor necrosis factor (TNF), proliferation, and cytotoxicity. Functionally, NKp46 expressed on mouse ILC1s interacts with tumor cells through cell\u2013cell contact, increasing ILC1 production of IFN-\u03b3 and TNF, and enhancing cytotoxicity. In a mouse model of acute myeloid leukemia, deletion of NKp46 impairs the ability of ILC1s to control tumor growth and reduces survival. This can be reversed by injecting NKp46<jats:sup>+<\/jats:sup> ILC1s into NKp46 knock-out mice. Human NKp46<jats:sup>+<\/jats:sup> ILC1s exhibit stronger cytokine production and cytotoxicity than their NKp46<jats:sup>\u2212<\/jats:sup> counterparts, suggesting that NKp46 plays a similar role in humans. These findings identify an NKp46\u2013NF-\u03baB\u2013IL-2R\u03b1 axis and suggest that activating NKp46 with an anti-NKp46 antibody may provide a potential strategy for anti-tumor innate immunity.<\/jats:p>","DOI":"10.1038\/s41467-025-55923-w","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:21:42Z","timestamp":1737728502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity"],"prefix":"10.1038","volume":"16","author":[{"given":"Rui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1171-4070","authenticated-orcid":false,"given":"Zhenlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1404-7830","authenticated-orcid":false,"given":"Tasha","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3459-7488","authenticated-orcid":false,"given":"Srividya","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-5908","authenticated-orcid":false,"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1181-3467","authenticated-orcid":false,"given":"Yong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4095-3020","authenticated-orcid":false,"given":"Michael A.","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-3223","authenticated-orcid":false,"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"55923_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6566","volume":"348","author":"G Eberl","year":"2015","unstructured":"Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. J. Innate lymphoid cells: a new paradigm in immunology. Science 348, aaa6566 (2015).","journal-title":"Science"},{"key":"55923_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells \u2014 a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"55923_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293\u2013301 (2015).","journal-title":"Nature"},{"key":"55923_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"55923_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2020.08.009","volume":"68","author":"C Seillet","year":"2021","unstructured":"Seillet, C., Brossay, L. & Vivier, E. Natural killers or ILC1s? That is the question. Curr. Opin. Immunol. 68, 48\u201353 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"55923_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/eji.201646871","volume":"47","author":"S Gabrielli","year":"2017","unstructured":"Gabrielli, S. et al. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements. Eur. J. Immunol. 47, 800\u2013805 (2017).","journal-title":"Eur. J. Immunol."},{"key":"55923_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","volume":"187","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. Cell 187, 624\u2013641.e623 (2024).","journal-title":"Cell"},{"key":"55923_CR8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","volume":"37","author":"T Hoyler","year":"2012","unstructured":"Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634\u2013648 (2012).","journal-title":"Immunity"},{"key":"55923_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ni1022","volume":"5","author":"G Eberl","year":"2004","unstructured":"Eberl, G. et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64\u201373 (2004).","journal-title":"Nat. Immunol."},{"key":"55923_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CSN Klose","year":"2014","unstructured":"Klose, C. S. N. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340\u2013356 (2014).","journal-title":"Cell"},{"key":"55923_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.immuni.2019.02.022","volume":"50","author":"W Xu","year":"2019","unstructured":"Xu, W. et al. An Id2(RFP)-reporter mouse redefines innate lymphoid cell precursor potentials. Immunity 50, 1054\u20131068.e1053 (2019).","journal-title":"Immunity"},{"key":"55923_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature20105","volume":"539","author":"Y Yu","year":"2016","unstructured":"Yu, Y. et al. Single-cell RNA-seq identifies a PD-1(hi) ILC progenitor and defines its development pathway. Nature 539, 102\u2013106 (2016).","journal-title":"Nature"},{"key":"55923_CR13","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1073\/pnas.1423244112","volume":"112","author":"MG Constantinides","year":"2015","unstructured":"Constantinides, M. G. et al. PLZF expression maps the early stages of ILC1 lineage development. Proc. Natl Acad. Sci. USA 112, 5123\u20135128 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55923_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","volume":"171","author":"OE Weizman","year":"2017","unstructured":"Weizman, O. E. et al. ILC1 confer early host protection at initial sites of viral infection. Cell 171, 795\u2013808.e712 (2017).","journal-title":"Cell"},{"key":"55923_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41590-019-0430-1","volume":"20","author":"OE Weizman","year":"2019","unstructured":"Weizman, O. E. et al. Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12. Nat. Immunol. 20, 1004\u20131011 (2019).","journal-title":"Nat. Immunol."},{"key":"55923_CR16","doi-asserted-by":"publisher","first-page":"e00617","DOI":"10.1128\/JVI.00617-19","volume":"93","author":"G Picarda","year":"2019","unstructured":"Picarda, G. et al. Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defenses. J. Virol. 93, e00617\u2013e00619 (2019).","journal-title":"J. Virol."},{"key":"55923_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.chom.2015.06.011","volume":"18","author":"MC Abt","year":"2015","unstructured":"Abt, M. C. et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18, 27\u201337 (2015).","journal-title":"Cell Host Microbe"},{"key":"55923_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.immuni.2020.12.004","volume":"54","author":"JP Shannon","year":"2021","unstructured":"Shannon, J. P. et al. Group 1 innate lymphoid-cell-derived interferon-\u03b3 maintains anti-viral vigilance in the mucosal epithelium. Immunity 54, 276\u2013290.e275 (2021).","journal-title":"Immunity"},{"key":"55923_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1084\/jem.20131560","volume":"211","author":"C Daussy","year":"2014","unstructured":"Daussy, C. et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211, 563\u2013577 (2014).","journal-title":"J. Exp. Med."},{"key":"55923_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.immuni.2016.03.007","volume":"44","author":"VS Cortez","year":"2016","unstructured":"Cortez, V. S. et al. Transforming growth factor-\u03b2 signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44, 1127\u20131139 (2016).","journal-title":"Immunity"},{"key":"55923_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ni.3800","volume":"18","author":"Y Gao","year":"2017","unstructured":"Gao, Y. et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat. Immunol. 18, 1004\u20131015 (2017).","journal-title":"Nat. Immunol."},{"key":"55923_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ni.3809","volume":"18","author":"VS Cortez","year":"2017","unstructured":"Cortez, V. S. et al. SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-\u03b2 signaling. Nat. Immunol. 18, 995\u20131003 (2017).","journal-title":"Nat. Immunol."},{"key":"55923_CR23","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1172\/JCI121227","volume":"128","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. SMAD4 promotes TGF-\u03b2-independent NK cell homeostasis and maturation and antitumor immunity. J. Clin. Invest. 128, 5123\u20135136 (2018).","journal-title":"J. Clin. Invest."},{"key":"55923_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone, L., Dumas, P. Y., Vienne, M. & Vivier, E. Natural killer cells and other innate lymphoid cells in cancer. Nat. Rev. Immunol. 18, 671\u2013688 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"55923_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cell.2016.01.002","volume":"164","author":"S Dadi","year":"2016","unstructured":"Dadi, S. et al. Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 164, 365\u2013377 (2016).","journal-title":"Cell"},{"key":"55923_CR26","doi-asserted-by":"publisher","first-page":"e2026271118","DOI":"10.1073\/pnas.2026271118","volume":"118","author":"L Ducimeti\u00e8re","year":"2021","unstructured":"Ducimeti\u00e8re, L. et al. Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc. Natl Acad. Sci. USA 118, e2026271118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55923_CR27","doi-asserted-by":"publisher","unstructured":"Song, J. et al. Requirement of ROR\u03b1 for maintenance and antitumor immunity of liver-resident natural killer cells\/ILC1s. Hepatology https:\/\/doi.org\/10.1002\/hep.32147 (2021).","DOI":"10.1002\/hep.32147"},{"key":"55923_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35095564","volume":"1","author":"A Cerwenka","year":"2001","unstructured":"Cerwenka, A. & Lanier, L. L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1, 41\u201349 (2001).","journal-title":"Nat. Rev. Immunol."},{"key":"55923_CR29","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.celrep.2018.03.023","volume":"22","author":"S Sheppard","year":"2018","unstructured":"Sheppard, S. et al. The murine natural cytotoxic receptor NKp46\/NCR1 controls TRAIL protein expression in NK cells and ILC1s. Cell Rep. 22, 3385\u20133392 (2018).","journal-title":"Cell Rep."},{"key":"55923_CR30","doi-asserted-by":"publisher","first-page":"e2004867","DOI":"10.1371\/journal.pbio.2004867","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Dong, W., Zhang, Y., Caligiuri, M. A. & Yu, J. Dependence of innate lymphoid cell 1 development on NKp46. PLoS Biol. 16, e2004867 (2018).","journal-title":"PLoS Biol."},{"key":"55923_CR31","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.4049\/jimmunol.1701333","volume":"200","author":"G Turchinovich","year":"2018","unstructured":"Turchinovich, G., Ganter, S., B\u00e4renwaldt, A. & Finke, D. NKp46 calibrates tumoricidal potential of type 1 innate lymphocytes by regulating TRAIL expression. J. Immunol. 200, 3762\u20133768 (2018).","journal-title":"J. Immunol."},{"key":"55923_CR32","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","volume":"17","author":"T Chinen","year":"2016","unstructured":"Chinen, T. et al. An essential role for the IL-2 receptor in T(reg) cell function. Nat. Immunol. 17, 1322\u20131333 (2016).","journal-title":"Nat. Immunol."},{"key":"55923_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li, H. B. et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature 548, 338\u2013342 (2017).","journal-title":"Nature"},{"key":"55923_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/JLB.1HI1017-396RR","volume":"104","author":"Y El-Darawish","year":"2018","unstructured":"El-Darawish, Y. et al. Frontline science: IL-18 primes murine NK cells for proliferation by promoting protein synthesis, survival, and autophagy. J. Leukoc. Biol. 104, 253\u2013264 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"55923_CR35","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1182\/blood-2012-12-471607","volume":"121","author":"S Sheppard","year":"2013","unstructured":"Sheppard, S. et al. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood 121, 5025\u20135033 (2013).","journal-title":"Blood"},{"key":"55923_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molimm.2017.06.025","volume":"88","author":"E Lusty","year":"2017","unstructured":"Lusty, E. et al. IL-18\/IL-15\/IL-12 synergy induces elevated and prolonged IFN-\u03b3 production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation. Mol. Immunol. 88, 138\u2013147 (2017).","journal-title":"Mol. Immunol."},{"key":"55923_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ni.2536","volume":"14","author":"JA Best","year":"2013","unstructured":"Best, J. A. et al. Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation. Nat. Immunol. 14, 404\u2013412 (2013).","journal-title":"Nat. Immunol."},{"key":"55923_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.it.2005.01.004","volume":"26","author":"LM Bradley","year":"2005","unstructured":"Bradley, L. M., Haynes, L. & Swain, S. L. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 26, 172\u2013176 (2005).","journal-title":"Trends Immunol."},{"key":"55923_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/imr.12644","volume":"283","author":"ME Raeber","year":"2018","unstructured":"Raeber, M. E., Zurbuchen, Y., Impellizzieri, D. & Boyman, O. The role of cytokines in T-cell memory in health and disease. Immunol. Rev. 283, 176\u2013193 (2018).","journal-title":"Immunol. Rev."},{"key":"55923_CR40","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1084\/jem.171.5.1509","volume":"171","author":"MA Caligiuri","year":"1990","unstructured":"Caligiuri, M. A. et al. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 171, 1509\u20131526 (1990).","journal-title":"J. Exp. Med."},{"key":"55923_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1172\/JCI6218","volume":"106","author":"TA Fehniger","year":"2000","unstructured":"Fehniger, T. A. et al. Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J. Clin. Invest. 106, 117\u2013124 (2000).","journal-title":"J. Clin. Invest."},{"key":"55923_CR42","doi-asserted-by":"publisher","first-page":"13759","DOI":"10.1073\/pnas.212214999","volume":"99","author":"HH Xue","year":"2002","unstructured":"Xue, H. H. et al. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc. Natl Acad. Sci. USA 99, 13759\u201313764 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55923_CR43","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.immuni.2021.07.019","volume":"54","author":"DC Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez, D. C. et al. An in vitro platform supports generation of human innate lymphoid cells from CD34(+) hematopoietic progenitors that recapitulate ex vivo identity. Immunity 54, 2417\u20132432.e2415 (2021).","journal-title":"Immunity"},{"key":"55923_CR44","doi-asserted-by":"publisher","first-page":"e1307491","DOI":"10.1080\/2162402X.2017.1307491","volume":"6","author":"AS Chretien","year":"2017","unstructured":"Chretien, A. S. et al. NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML. Oncoimmunology 6, e1307491 (2017).","journal-title":"Oncoimmunology"},{"key":"55923_CR45","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1073\/pnas.0609692104","volume":"104","author":"T Walzer","year":"2007","unstructured":"Walzer, T. et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl Acad. Sci. USA 104, 3384\u20133389 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55923_CR46","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.4049\/jimmunol.0801878","volume":"182","author":"GG Halfteck","year":"2009","unstructured":"Halfteck, G. G. et al. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46\/NCR1. J. Immunol. 182, 2221\u20132230 (2009).","journal-title":"J. Immunol."},{"key":"55923_CR47","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41590-022-01198-y","volume":"23","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. ILC1s control leukemia stem cell fate and limit development of AML. Nat. Immunol. 23, 718\u2013730 (2022).","journal-title":"Nat. Immunol."},{"key":"55923_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-022-01243-1","volume":"15","author":"S Ma","year":"2022","unstructured":"Ma, S., Caligiuri, M. A. & Yu, J. A four-stage model for murine natural killer cell development in vivo. J. Hematol. Oncol. 15, 31 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"55923_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink, J. H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221\u2013229 (2013).","journal-title":"Nat. Immunol."},{"key":"55923_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink, J. H. et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146\u2013160 (2015).","journal-title":"Immunity"},{"key":"55923_CR51","doi-asserted-by":"publisher","first-page":"e1475875","DOI":"10.1080\/2162402X.2018.1475875","volume":"7","author":"FF Almeida","year":"2018","unstructured":"Almeida, F. F. et al. A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets. Oncoimmunology 7, e1475875 (2018).","journal-title":"Oncoimmunology"},{"key":"55923_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07405-5","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Memory formation and long-term maintenance of IL-7R\u03b1(+) ILC1s via a lymph node-liver axis. Nat. Commun. 9, 4854 (2018).","journal-title":"Nat. Commun."},{"key":"55923_CR53","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20151403","volume":"212","author":"C Song","year":"2015","unstructured":"Song, C. et al. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212, 1869\u20131882 (2015).","journal-title":"J. Exp. Med."},{"key":"55923_CR54","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ni.3816","volume":"18","author":"B Kwong","year":"2017","unstructured":"Kwong, B. et al. T-bet-dependent NKp46(+) innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nat. Immunol. 18, 1117\u20131127 (2017).","journal-title":"Nat. Immunol."},{"key":"55923_CR55","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1126\/science.1103478","volume":"306","author":"E Vivier","year":"2004","unstructured":"Vivier, E. & Nun\u00e8s, J. A. & V\u00e9ly, F. Natural killer cell signaling pathways. Science 306, 1517\u20131519 (2004).","journal-title":"Science"},{"key":"55923_CR56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2005-04-1351","volume":"107","author":"YT Bryceson","year":"2006","unstructured":"Bryceson, Y. T., March, M. E., Ljunggren, H. G. & Long, E. O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107, 159\u2013166 (2006).","journal-title":"Blood"},{"key":"55923_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11686","volume":"7","author":"HJ Kwon","year":"2016","unstructured":"Kwon, H. J. et al. Stepwise phosphorylation of p65 promotes NF-\u03baB activation and NK cell responses during target cell recognition. Nat. Commun. 7, 11686 (2016).","journal-title":"Nat. Commun."},{"key":"55923_CR58","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.3324\/haematol.2014.119602","volume":"100","author":"S Trabanelli","year":"2015","unstructured":"Trabanelli, S. et al. CD127+ innate lymphoid cells are dysregulated in treatment na\u00efve acute myeloid leukemia patients at diagnosis. Haematologica 100, e257\u2013260 (2015).","journal-title":"Haematologica"},{"key":"55923_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ni1322","volume":"7","author":"R Gazit","year":"2006","unstructured":"Gazit, R. et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7, 517\u2013523 (2006).","journal-title":"Nat. Immunol."},{"key":"55923_CR60","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","volume":"23","author":"J Ren","year":"2017","unstructured":"Ren, J. et al. Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin. Cancer Res. 23, 2255\u20132266 (2017).","journal-title":"Clin. Cancer Res."},{"key":"55923_CR61","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"55923_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"55923_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"55923_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"55923_CR65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"55923_CR66","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55923_CR67","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55923-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:58:19Z","timestamp":1737730699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55923-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55923"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-55923-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"989"}}